Your browser doesn't support javascript.
loading
Impact of Sequencing Radiation Therapy and Immune Checkpoint Inhibitors in the Treatment of Melanoma Brain Metastases.
Pomeranz Krummel, Daniel A; Nasti, Tahseen H; Izar, Benjamin; Press, Robert H; Xu, Maxwell; Lowder, Lindsey; Kallay, Laura; Rupji, Manali; Rosen, Havi; Su, Jing; Curran, Walter; Olson, Jeffrey; Weinberg, Brent; Schniederjan, Matthew; Neill, Stewart; Lawson, David; Kowalski, Jeanne; Khan, Mohammad K; Sengupta, Soma.
Afiliação
  • Pomeranz Krummel DA; Department of Neurology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Nasti TH; Department of Microbiology and Immunology, Emory University, Atlanta, Georgia.
  • Izar B; Columbia Center for Translational Immunology, Columbia University Medical Center, New York City, New York.
  • Press RH; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia.
  • Xu M; Department of Neurology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Lowder L; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Kallay L; Department of Neurology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Rupji M; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.
  • Rosen H; Department of Neurology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Su J; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Curran W; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.
  • Olson J; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia; Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia.
  • Weinberg B; Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia.
  • Schniederjan M; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Neill S; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Lawson D; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.
  • Kowalski J; Department of Oncology, LIVESTRONG Cancer Institutes, Dell Medical School, University of Texas, Austin, Texas.
  • Khan MK; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia. Electronic address: drkhurram2000@gmail.com.
  • Sengupta S; Department of Neurology, University of Cincinnati College of Medicine, Cincinnati, Ohio; University of Cincinnati Gardner Neuroscience Institute, Cincinnati, Ohio. Electronic address: soma.sengupta@uc.edu.
Int J Radiat Oncol Biol Phys ; 108(1): 157-163, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32057994
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article